Eikon Therapeutics, Inc. Common Stock (EIKN) vs MapLight Therapeutics, Inc. (MPLT)

A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and MapLight Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$407M
$7.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MapLight Therapeutics, Inc. logo
MPLT
MapLight Therapeutics, Inc.
$411M
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EIKN vs MPLT

growth of $100 · dividends reinvested · last 1y
EIKN -49.7% (-49.7%/yr)MPLT -40.9% (-40.9%/yr)MPLT compounded faster over this window
50100150200250Start $100$50$59
EIKN MPLT

EIKN vs MPLT: by the numbers

  • •MPLT is the larger company ($411M vs $407M market cap).

Metrics side by side

Valuation

MetricEIKNMPLT
P/B ratio0.871.18

Profitability

MetricEIKNMPLT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-69.06%-65.99%
ROIC-46.16%-69.35%

Go deeper

Full EIKN analysisFull MPLT analysisInteractive comparison tool

Dig into the metrics

Eikon Therapeutics, Inc. Common Stock ROEMapLight Therapeutics ROEEikon Therapeutics, Inc. Common Stock operating marginMapLight Therapeutics operating marginEikon Therapeutics, Inc. Common Stock revenue growthMapLight Therapeutics revenue growthEikon Therapeutics, Inc. Common Stock free cash flowMapLight Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.